Old Web
English
Sign In
Acemap
>
authorDetail
>
W. Jonathan Kell
W. Jonathan Kell
Medicine
Myeloid leukemia
Chemotherapy
Internal medicine
Clofarabine
3
Papers
189
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
fit for intensive chemotherapy treatment for older patients with acute myeloid leukemia not considered A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line
2013
Richard L. Clark
Mark Levis
Donald Small
Steven Knapper
Alan K. Burnett
Tim Littlewood
W. Jonathan Kell
Sam Agrawal
Raj Chopra
Show All
Source
Cite
Save
Citations (1)
European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.
2010
Journal of Clinical Oncology
Alan Kenneth Burnett
Nigel H. Russell
W. Jonathan Kell
Michael Dennis
Donald Milligan
Stefania Paolini
John A. Liu Yin
Dominic Culligan
Peter W. Johnston
John J. Murphy
Mary Frances McMullin
Ann Hunter
Emma Das-Gupta
Richard E. Clark
Robert Carr
Robert Kerrin Hills
Show All
Source
Cite
Save
Citations (140)
Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells
2006
Blood
Richard G. Goodwin
W. Jonathan Kell
Peter Laidler
Colin Long
Sharon D. Whatley
Mark McKinley
Michael Norman Badminton
Alan Kenneth Burnett
Geraint Trefor Williams
George H. Elder
Show All
Source
Cite
Save
Citations (48)
1